Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 2 of 2

Full-Text Articles in Entire DC Network

Compensation Crisis Related To The Onsite Adequacy Evaluation During Fna Procedures-Urgent Proactive Input From Cytopathology Community Is Critical To Establish Appropriate Reimbursement For Cpt Code 88172 (Or Its New Counterpart If Introduced In The Future), Inderpreet Dhillon, Martha B. Pitman, Richard M. Demay, Pamela Archuletta, Vinod B. Shidham Oct 2010

Compensation Crisis Related To The Onsite Adequacy Evaluation During Fna Procedures-Urgent Proactive Input From Cytopathology Community Is Critical To Establish Appropriate Reimbursement For Cpt Code 88172 (Or Its New Counterpart If Introduced In The Future), Inderpreet Dhillon, Martha B. Pitman, Richard M. Demay, Pamela Archuletta, Vinod B. Shidham

Department of Pathology

The confusion centered around appropriate use of the CPT billing code 88172 is addressed in the commentary from the Economic and Government Affairs Committee of the American Society of Cytopathology (ASC) who have written a timely commentary in this issue of Cytojournal,“Adequate Reimbursement is Crucial to Support Cost-Effective Rapid Onsite Cytopathology Evaluations”. Currently, lack of standardized use within and between pathology departments is stirring unhealthy practices of denying reimbursements for this critical and legitimate cytopathology service. This editorial discusses the important concerns raised in this commentary and recommends immediate corrective action. (See also Al-Abbadi MA, et al. Adequate reimbursement is …


Performing And Processing Fna Of Anterior Fat Pad For Amyloid, Vinod B. Shidham, Bryan Hunt, Safwan S. Jaradeh, Alexandru C. Barboi, Sumana Devata, Parameswaran Hari Oct 2010

Performing And Processing Fna Of Anterior Fat Pad For Amyloid, Vinod B. Shidham, Bryan Hunt, Safwan S. Jaradeh, Alexandru C. Barboi, Sumana Devata, Parameswaran Hari

Department of Pathology

Historically, heart, liver, and kidney biopsies were performed to demonstrate amyloid deposits in amyloidosis. Since the clinical presentation of this disease is so variable and non-specific, the associated risks of these biopsies are too great for the diagnostic yield. Other sites that have a lower biopsy risk, such as skin or gingival, are also relatively invasive and expensive. In addition, these biopsies may not always have sufficient amyloid deposits to establish a diagnosis. Fat pad aspiration has demonstrated good clinical correlation with low cost and minimal morbidity. However, there are no standardized protocols for performing this procedure or processing the …